News for IceCure Medical Ltd (ICUSF)

PR NewswireCAESAREA, Israel, March 10, 2025 Independent study published in Gland Surgery and conducted at Kameda Medical Center in Japan by ProSense® user

PR NewswireCAESAREA, Israel, Feb. 24, 2025 Application covering a wide range of indications is in line with trends in de-escalation of surgery and growth i

PR NewswireCAESAREA, Israel, Jan. 27, 2025 Seeks to expand regulatory approval in China where IceSense3 has already been approvedCAESAREA, Israel, Jan. 27,

PR NewswireCAESAREA, Israel, Jan. 6, 2025 CAESAREA, Israel, Jan. 6, 2025 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical"

PR NewswireCAESAREA, Israel, Jan. 3, 2025 XSenseâ„¢ system's innovative cryogenic connector technology designed to improve safety and maintain the integrit

PR NewswireCAESAREA, Israel, Dec. 5, 2024 Data confirm previous results showing that ProSense® cryoablation is highly effective for kidney tumors < 3 cm a

IceCure Medical Ltd (NASDAQ:ICCM) Q3 2024 Earnings Conference Call November 26, 2024 10:00 AM ETCompany ParticipantsMichael Polyviou - IRRonen Tsimerman -...

IceCure Medical (ICCM) delivered earnings and revenue surprises of -14.29% and 5.43%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

PR NewswireCAESAREA, Israel, Nov. 26, 2024 FDA Marketing Authorization Decision on Early Stage-Low Risk Breast Cancer Expected in Q1 2025Conference call to

PR NewswireCAESAREA, Israel, Nov. 25, 2024 Invention facilitates treatment of larger tumors and is a significant leap forward in the field of cryoablationC

PR NewswireCAESAREA, Israel, Nov. 19, 2024 PRECICE study, financed by the Umberto Veronesi Foundation and the Italian Ministry of Health, is led by multidi

Edwards Lifesciences (EW) saw its stock surge by 5%, trading at $67.77 per share with a volume of 2.42 million shares. The stock witnessed a turnover rate of 0.

ICCM stock touches 52-week low at $0.48 amid market challenges

Loading... Loading... Shares of Nurix Therapeutics, Inc. NRIX rose sharply in today's pre-market trading after the company announced results from its ongoing c...

Chicago, June 14, 2024 (GLOBE NEWSWIRE) -- Discover the lucrative potential of the global tumor ablation market projected to soar from $0.8 billion in...

Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million public offering.

Gainers Maris-Tech Ltd. (NASDAQ: MTEK) shares rose 38% to $1.38 in pre-market trading, after gaining 6% on Friday. Maris-Tech, on Friday, disclosed the launch of Jupiter Drones, an innovative, drone-oriented solution based on Maris-Tech's Jupiter Nano platform.